Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies

Keyphrases

• Clinical Utility 100%
• Kallikrein-related Peptidases 100%
• Urological Malignancies 100%
• Urogenital Tract 66%
• Testicle 33%
• Tumor 33%
• Malignancy 33%
• Failure Prediction 33%
• Early Diagnosis 33%
• Cancer Stage 33%
• Lung 33%
• Cancer Types 33%
• Response Prediction 33%
• Gastrointestinal Tract 33%
• Ovarian Cancer 33%
• Urinary Bladder 33%
• Molecular Classification 33%
• International Research 33%
• Cancer Progression 33%
• Head-and-neck 33%
• Human Malignancies 33%
• Normal Prostate 33%
• Uterus 33%
• Early Prognosis 33%
• Proteolytic System 33%
• Human Prediction 33%
• Cancer Metastasis 33%
• Kidney Cancer 33%
• Janus Face 33%
• Normal Kidney 33%

Medicine and Dentistry

• Cancer 100%
• Peptidase 100%
• Kallikrein 100%
• Biological Marker 50%
• Malignant Neoplasm 50%
• Neoplasm 25%
• Neck 25%
• Cancer Staging 25%
• Lung 25%
• Metastatic Carcinoma 25%
• Early Diagnosis 25%
• Bladder 25%
• Gastrointestinal Tract 25%
• Cancer Growth 25%
• Ovarian Cancer 25%
• Testes 25%
• Kidney Cancer 25%

Biochemistry, Genetics and Molecular Biology

• Kallikrein 100%
• Peptidase 100%
• Gastrointestinal Tract 33%
• Cancer Staging 33%